A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
Clinical trial NCT03463135 · COMPLETED
Trial details
- NCT number
- NCT03463135
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-07
- Primary completion
- 2019-05-08
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.